Safeguard Scientifics, Inc. (NYSE:SFE) – Analysts at Barrington Research issued their FY2018 earnings per share estimates for shares of Safeguard Scientifics in a report released on Tuesday, Zacks Investment Research reports. Barrington Research analyst A. Paris. Jr anticipates that the asset manager will earn ($2.95) per share for the year. Barrington Research currently has a “Buy” rating and a $20.00 price target on the stock. Barrington Research also issued estimates for Safeguard Scientifics’ FY2019 earnings at ($3.21) EPS.
A number of other equities research analysts also recently commented on SFE. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $14.50 price objective on shares of Safeguard Scientifics in a report on Thursday, March 1st. Zacks Investment Research downgraded Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. Safeguard Scientifics has an average rating of “Hold” and an average price target of $15.83.
Shares of Safeguard Scientifics (NYSE:SFE) opened at $12.50 on Thursday. The company has a market capitalization of $256.18, a PE ratio of -2.89 and a beta of 1.31. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.55. Safeguard Scientifics has a fifty-two week low of $10.65 and a fifty-two week high of $14.40.
Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings data on Thursday, March 1st. The asset manager reported ($0.91) EPS for the quarter, beating analysts’ consensus estimates of ($1.05) by $0.14. During the same period in the prior year, the company posted ($1.07) earnings per share.
A number of large investors have recently bought and sold shares of SFE. Ariel Investments LLC grew its stake in Safeguard Scientifics by 18.7% in the fourth quarter. Ariel Investments LLC now owns 1,501,367 shares of the asset manager’s stock valued at $16,815,000 after acquiring an additional 236,758 shares during the period. Deutsche Bank AG grew its stake in Safeguard Scientifics by 27.1% in the fourth quarter. Deutsche Bank AG now owns 534,475 shares of the asset manager’s stock valued at $5,984,000 after acquiring an additional 114,125 shares during the period. Granahan Investment Management Inc. MA grew its stake in Safeguard Scientifics by 20.8% in the third quarter. Granahan Investment Management Inc. MA now owns 646,492 shares of the asset manager’s stock valued at $8,631,000 after acquiring an additional 111,370 shares during the period. Renaissance Technologies LLC grew its stake in Safeguard Scientifics by 42.5% in the fourth quarter. Renaissance Technologies LLC now owns 309,417 shares of the asset manager’s stock valued at $3,465,000 after acquiring an additional 92,300 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in Safeguard Scientifics by 6.6% in the second quarter. Dimensional Fund Advisors LP now owns 1,147,008 shares of the asset manager’s stock valued at $13,649,000 after acquiring an additional 71,379 shares during the period. 76.54% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/03/18/safeguard-scientifics-inc-sfe-expected-to-earn-fy2018-earnings-of-2-95-per-share.html.
About Safeguard Scientifics
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings in Fintech sector. It initially invests in a Series A-C round and opportunistically in a seed round.
Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.